Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)’s Basic Consolidated EPS Came In At $-0.4612

0

The annual basic consolidated EPS for Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) posted annual basic consolidated EPS of $-0.4612 for the year period ended2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-0.4612.

What About EPS from continuing operations

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)’s EPS from continuing operations for the annual period ended 2015-12-31 came in at -0.4612. On quarterly basis, EPS from continuing operations stood at $-0.4612 for the three-month period ended 2015-12-31.

EPS contribution from parent

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) received of $-0.4612 EPS boost from the parent company for the annual period ended 2015-12-31. For the quarter period ended 2015-12-31, the company received EPS boost of $-0.4612 from its parent company.

What About Basic net EPS

The company’s basic net EPS for the annual period ended 2015-12-31 was$-0.46, but for the quarter period ended 2015-12-31 the basic net EPS was $-0.46.

What About Consolidated Diluted EPS?

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) posted consolidated diluted EPS of $-0.4612 for the annual period ended 2015-12-31. On the other hand, consolidated diluted EPS for the quarterly period ended 2015-12-31 stood at $-0.4612.

Basic diluted EPS

The company’s diluted EPS from continuing operation stood at $-0.4612 for the annual period ended 2015-12-31. On quarter basis, diluted EPS from continuing operations was $-0.4612 for the three-month period ended 2015-12-31.

Net diluted EPS

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) posted net diluted EPS of $-0.46for the annual period ended 2015-12-31. On the other hand, it posted net diluted EPS of $-0.46 for thequarterly period ended 2015-12-31.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) contributed diluted EPS of $-0.4612. The diluted EPS contribution from the parent for the quarter ended 2015-12-31 stood at $-0.4612.

The company’s net basic EPS for the annual period ended 2015-12-31 was $-0.46 while for the quarter period ended 2015-12-31 it was $-0.46.

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) had average basic shares outstanding of 18.406 for the annual period ended 2015-12-31 and 18.406 for the quarter period ended 2015-12-31.The number of diluted shares outstanding was 18.406 for the annual period ended 2015-12-31 and 18.406 for the quarter ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 53 times, 1 visits today)